BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33299579)

  • 21. Outpatient-based high-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Dyk PT; Richardson S; Badiyan SN; Schwarz JK; Esthappan J; Garcia-Ramirez JL; Grigsby PW
    Brachytherapy; 2015; 14(2):231-7. PubMed ID: 25556865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience.
    Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Okazawa M; Sasano T; Maruoka S; Anzai M; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2014 Jan; 24(1):141-8. PubMed ID: 24362719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
    Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
    Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers.
    Varela Cagetti L; Zemmour C; Salem N; Minsat M; Ferrè M; Mailleux H; Giovaninni M; Lelong B; De Chaisemartin C; Ries P; Poizat F; Tallet A; Moureau-Zabotto L
    Brachytherapy; 2019; 18(6):814-822. PubMed ID: 31515067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients.
    Marina O; Gustafson GS; Kestin LL; Brabbins DS; Chen PY; Ye H; Martinez AA; Ghilezan MI; Wallace M; Krauss DJ
    Brachytherapy; 2014; 13(1):59-67. PubMed ID: 23871661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome of high-dose-rate interstitial brachytherapy in vulvar cancer: A single institutional experience.
    Mahantshetty U; Naga P; Engineer R; Sastri S; Ghadi Y; Upreti U; Somesan V; Kadam S; Kohle S; Deshpande D; Shrivastava SK
    Brachytherapy; 2017; 16(1):153-160. PubMed ID: 27876410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma.
    Uchimoto Y; Shimamoto H; Takeshita A; Oya K; Kishino M; Fukuda Y; Toyosawa S; Oda M; Ogawa K; Kreiborg S; Mallya SM; Murakami S
    J Contemp Brachytherapy; 2022 Jun; 14(3):268-272. PubMed ID: 36199998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage High-dose-rate Interstitial Brachytherapy for Pelvic Recurrent Cervical Carcinoma After Hysterectomy.
    Murakami N; Kato T; Miyamoto Y; Nakamura S; Wakita A; Okamoto H; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Takahashi K; Umezawa R; Inaba K; Ito Y; Igaki H; Itami J
    Anticancer Res; 2016 May; 36(5):2413-21. PubMed ID: 27127151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric comparison of vaginal vault ovoid brachytherapy versus intensity-modulated radiation therapy plans in postoperative patients of cervical carcinoma following whole pelvic radiotherapy.
    Khosla D; Patel FD; Oinam AS; Tomar P; Sharma SC
    J Cancer Res Ther; 2014; 10(1):153-8. PubMed ID: 24762503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
    Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P
    Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Petersen JB; Nielsen SK; Lindegaard JC; Tanderup K
    Acta Oncol; 2008; 47(7):1337-43. PubMed ID: 18663651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma - a case report.
    Takagawa Y; Murakami N; Igaki H; Okamoto H; Itami J
    J Contemp Brachytherapy; 2022 Apr; 14(2):198-204. PubMed ID: 35494187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary results of magnetic resonance imaging-aided high-dose-rate interstitial brachytherapy for recurrent uterine carcinoma after curative surgery.
    Kotsuma T; Yoshida K; Yamazaki H; Takenaka T; Konishi K; Isohashi F; Koizumi M; Tanaka E; Yoshioka Y
    J Radiat Res; 2011; 52(3):329-34. PubMed ID: 21467737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Image-guided high-dose-rate interstitial brachytherapy boost in the radical radiotherapy for a huge metastatic carcinoma of cervical lymph nodes from an unknown primary site.
    Wang M; Wu N; Han D; Zhao H; Cheng G
    Cancer Radiother; 2019 Sep; 23(5):426-431. PubMed ID: 31255579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Customized individual applicators for endocavitary brachytherapy in patients with cancers of the nasal cavity, sinonasal region and nasopharynx.
    Kadah BA; Niewald M; Papaspyrou G; Dzierma Y; Schneider M; Schick B
    Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1543-7. PubMed ID: 25905695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach.
    Draghini L; Costantini S; Vicenzi L; Italiani M; Loreti F; Trippa F; Arcidiacono F; Casale M; Mantello G; Maranzano E
    Radiol Med; 2019 Sep; 124(9):819-825. PubMed ID: 30904982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage.
    Duan J; Kim RY; Elassal S; Lin HY; Shen S
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):765-71. PubMed ID: 18164832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.